PUBLISHER: The Business Research Company | PRODUCT CODE: 1942826
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942826
Enzyme-linked immunosorbent assay (ELISA) analyzers are automated laboratory instruments designed to detect and quantify biological substances in different sample types. They work by using antibodies and antigens that bind together, along with enzyme-linked reagents that produce visible signals-often color changes-that indicate the amount of the target analyte present. These analyzers enhance diagnostic accuracy, consistency, and speed in clinical laboratories, while reducing human error and boosting overall lab efficiency.
The main types of enzyme-linked immunosorbent assay (ELISA) analyzers include benchtop ELISA analyzers, portable ELISA analyzers, automated ELISA workstations, and microplate readers. Benchtop ELISA analyzers are fixed lab instruments intended for high-volume, accurate detection of biomolecules such as proteins, antibodies, and antigens in both clinical and research environments. They employ various technologies, including colorimetric, fluorescence, chemiluminescence, and electrochemical ELISA methods, and serve multiple applications like vaccine development, immunology, diagnostics, toxicology, drug monitoring, and pharmaceutical manufacturing. These devices are utilized by a variety of end-users including diagnostic laboratories, research centers, pharmaceutical companies, the food and beverage industry, and academic institutions.
Tariffs are influencing the ELISA analyzers market by increasing costs of imported optical components, microplate readers, precision electronics, reagents handling systems, and automation hardware. Diagnostic laboratories and research institutions in North America and Europe are most affected due to reliance on imported analytical equipment, while Asia-Pacific faces cost pressures on analyzer exports. These tariffs are increasing capital investment requirements and delaying laboratory upgrades. However, they are also encouraging regional manufacturing, local assembly of analyzers, and innovation in cost-efficient diagnostic platforms.
The enzyme-linked immunosorbent assay (elisa) analyzers market research report is one of a series of new reports from The Business Research Company that provides enzyme-linked immunosorbent assay (elisa) analyzers market statistics, including enzyme-linked immunosorbent assay (elisa) analyzers industry global market size, regional shares, competitors with a enzyme-linked immunosorbent assay (elisa) analyzers market share, detailed enzyme-linked immunosorbent assay (elisa) analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme-linked immunosorbent assay (elisa) analyzers industry. This enzyme-linked immunosorbent assay (elisa) analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The enzyme-linked immunosorbent assay (elisa) analyzers market size has grown strongly in recent years. It will grow from $0.75 billion in 2025 to $0.8 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to expansion of clinical diagnostic testing volumes, growth in infectious disease screening, adoption of automated laboratory instruments, rising demand for reliable immunoassays, availability of standardized diagnostic protocols.
The enzyme-linked immunosorbent assay (elisa) analyzers market size is expected to see strong growth in the next few years. It will grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing investments in advanced diagnostics infrastructure, rising adoption of point-of-care testing solutions, expansion of pharmaceutical and vaccine research, growing focus on laboratory efficiency, increasing demand for rapid and accurate assays. Major trends in the forecast period include increasing adoption of fully automated elisa workstations, rising demand for high-throughput diagnostic testing, growing use of chemiluminescence and fluorescence technologies, expansion of portable elisa analyzer usage, enhanced focus on laboratory workflow automation.
The growing incidence of infectious diseases is expected to drive the expansion of the enzyme-linked immunosorbent assay (ELISA) analyzers market in the coming years. Infectious diseases are conditions caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, that can spread through direct or indirect transmission. The increasing prevalence of these diseases is largely linked to greater human interaction with the environment and rising global connectivity. ELISA analyzers aid in identifying infectious diseases by detecting specific antibodies or antigens in blood samples, enabling fast and precise diagnosis that supports effective monitoring and control of disease outbreaks. For example, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental body, an estimated 10.8 million people worldwide were affected by tuberculosis in 2023, including 6.0 million men, 3.6 million women, and 1.3 million children. Therefore, the increasing burden of infectious diseases is contributing to the growth of the enzyme-linked immunosorbent assay (ELISA) analyzers market.
Major companies operating in the enzyme-linked immunosorbent assay (ELISA) analyzers market are focusing on technological innovations, such as fully automated ELISA workstations, to support high-throughput testing, minimize manual intervention, and enhance data accuracy. A fully automated ELISA workstation combines processes such as sample dispensing, reagent management, incubation, washing, and detection into a single system, unlike manual or semi-automated setups, enabling unattended operation, consistent outcomes, and compliance with regulatory data standards. For instance, in November 2023, DYNEX Technologies, a US-based life sciences instrumentation company, introduced the Agility Integra fully automated ELISA system. This system supports the simultaneous processing of multiple ELISA assays, includes 21 CFR Part 11-compliant software for secure and traceable data handling, reduces hands-on time by up to 60%, and improves throughput and workflow efficiency in clinical diagnostics and research laboratories.
In April 2023, DYNEX Technologies Inc., a US-based supplier of automated enzyme-linked immunosorbent assay (ELISA) systems, entered into a partnership with Tecan Group Ltd. to enhance access to high-quality ELISA solutions for laboratories in the United States. Through this collaboration, DYNEX aims to broaden the availability of ELISA immunoassay products in the US market by integrating Tecan's specialized assay kits with its automated platforms. Tecan Group Ltd. is a Switzerland-based provider of benchtop microplate readers.
Major companies operating in the enzyme-linked immunosorbent assay (elisa) analyzers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., BioMerieux, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., EUROIMMUN Medizinische Labordiagnostika AG, Molecular Devices LLC, Quanterix, Berthold Technologies GmbH and Co. KG, Trinity Biotech Public Limited Company, Erba Mannheim GmbH, Dynex Technologies Inc., BMG Labtech GmbH, Awareness Technology Inc., Medicon Hellas S.A., Adaltis S.r.l., Gold Standard Diagnostics Corp.
North America was the largest region in the enzyme-linked immunosorbent assay (ELISA) analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme-linked immunosorbent assay (elisa) analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the enzyme-linked immunosorbent assay (elisa) analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The enzyme-linked immunosorbent assay (ELISA) analyzers market consists of revenues earned by entities by providing services such as installation and calibration of analyzers, maintenance and technical support, training for laboratory personnel, software integration and upgrades, and validation and quality assurance services. The market value includes the value of related goods sold by the service provider or included within the service offering. enzyme-linked immunosorbent assay (ELISA) analyzers market also includes sales of ELISA plate washers, ELISA incubators, ELISA reagent dispensers, ELISA control and calibration systems, and hybrid ELISA platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses enzyme-linked immunosorbent assay (elisa) analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for enzyme-linked immunosorbent assay (elisa) analyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enzyme-linked immunosorbent assay (elisa) analyzers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.